Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant

Project: Research

Project Details

StatusFinished
Effective start/end date03/17/16 → 03/16/20

Funding

  • CTI Clinical Trial Services Incorporated: $148,187.10